GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Epi Biotech Co Ltd (XKRX:446440) » Definitions » Accounts Receivable

Epi Biotech Co (XKRX:446440) Accounts Receivable : ₩0.00 Mil (As of . 20)


View and export this data going back to 2023. Start your Free Trial

What is Epi Biotech Co Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Epi Biotech Co's accounts receivables for the quarter that ended in . 20 was ₩0.00 Mil.

Accounts receivable can be measured by Days Sales Outstanding.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Epi Biotech Co's Net-Net Working Capital per share for the quarter that ended in . 20 was ₩N/A.


Epi Biotech Co Accounts Receivable Historical Data

The historical data trend for Epi Biotech Co's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Epi Biotech Co Accounts Receivable Chart

Epi Biotech Co Annual Data
Trend
Accounts Receivable

Epi Biotech Co Semi-Annual Data
Accounts Receivable

Epi Biotech Co Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.


Epi Biotech Co Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Epi Biotech Co's Days Sales Outstanding for the quarter that ended in . 20 is calculated as:

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Epi Biotech Co's accounts receivable are only considered to be worth 75% of book value:

Epi Biotech Co's Net-Net Working Capital Per Share for the quarter that ended in . 20 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(+0.75 * +0.5 * -N/A
--)/0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


Epi Biotech Co Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Epi Biotech Co's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Epi Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
32, Songdogwahak-ro, Rooms 1903 and 1904, 15th floor, M-dong, Yeonsu-gu, Incheon, KOR, 21984
Epi Biotech Co Ltd is developing various pipelines for each hair loss treatment modality. It also conducts R&D in skin regeneration treatments to create commercially viable consumer products. The company specializes in hair loss treatment in Korea.

Epi Biotech Co Headlines

No Headlines